Elmo2 is an essential regulator of carotid artery development
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA1169836 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR30902940_1.fastq.gz | Fastqsanger.gz | |||
| SRR30902940_2.fastq.gz | Fastqsanger.gz | |||
| SRR30902941_1.fastq.gz | Fastqsanger.gz | |||
| SRR30902941_2.fastq.gz | Fastqsanger.gz | |||
| SRR30902942_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 6 |
Similar Datasets
Project description:Engulfment and cell motility 2 (ELMO2) is a cytoskeletal adaptor protein. Loss of function mutations in ELMO2 are associated with a life-threatening human disease called intraosseous vascular malformation (VMOS). This autosomal recessive disease manifests in the craniofacial area and has no effective treatment, in part due to the poor characterization of its physiopathology. In this study, we report the first detailed characterization of Elmo2 global deletion in mice and showcase the importance of Elmo2 during cardiovascular development. Elmo2 was found to be indispensable for normal morphogenesis of the third pharyngeal arch artery (3rd PAA) which gives rise to the common carotid artery, responsible for the blood supply to the craniofacial region. Global deletion of Elmo2 induces severe dilation in the 3rd PAAs and aneurism formation in the carotid arteries leading to embryonic lethality. Elmo2-deficient embryos showed impaired cytoskeletal organization in neural crest-derived vascular smooth muscle cells (VSMCs) and defects in the endothelial lining of the dilated arteries. Deletion of Elmo2 specifically in neural crest cells phenocopied all the relevant defects observed in the global knockout while gene inactivation in endothelial cells, sympathetic neurons and mature VSMCs had no effect or induced only minor changes in vessel diameter. Furthermore, time-controlled ubiquitous deletion of Elmo2 allowed us to conclude that early gene inactivation is necessary for recapitulating the major defects observed in Elmo2-null embryos. In addition, analysis of cultured neural crest-derived human brain VSMCs showed decreased active RAC1 and F-actin levels upon ELMO2 downregulation, which impair adhesion, spreading and cell contractility. These defects can be rescued in vitro through administration of the F-actin stabilizer Jasplakinolide. Altogether our results highlight a previously unappreciated role for Elmo2 in the physiology of neural crest-derived VSMCs. These findings might be relevant for understanding the cellular mechanisms responsible for VMOS.
2025-05-05 | GSE278960 | GEO
Project description:Analysis of carotid artery vessels from wild-type and collagen type VIII deletion mice
2021-05-13 | MSV000087422 | MassIVE
Project description:The proliferation and remodeling of vascular smooth muscle cells (VSMCs) is an important pathological event in atherosclerosis and restenosis. Here we report that microRNA-132 (miR-132) blocks vascular smooth muscle cells (VSMC) proliferation by inhibiting the expression of LRRFIP1 [leucine-rich repeat (in Flightless 1) interacting protein-1]. MicroRNA microarray revealed that miR-132 was upregulated in the rat carotid artery after catheter injury, which was further confirmed by quantitative real-time RT-PCR. Transfection of an miR-132 mimic significantly inhibited the proliferation of VSMCs, whereas transfection of an miR-132 antagomir increased it. Bioinformatics showed that LRRFIP1 is a target candidate of miR-132. miR-132 down-regulated luciferase activity driven by a vector containing the 3’-untranslated region of Lrrfip1 in a sequence-specific manner. LRRFIP1 induced VSMC proliferation. Immunohistochemical analysis revealed that Lrrfip1 was clearly expressed along with the basal laminar area of smooth muscle, and its expression pattern was disrupted 7 days after arterial injury LRRFIP1 mRNA was decreased 14 days after injury. Delivery of miR-132 to rat carotid artery attenuated neointimal proliferation in carotid artery injury models. Our results suggest that miR-132 is a novel regulator of VSMC proliferation that represses neointimal formation by inhibiting LRRFIP1 expression. Balloon injury was induced in the carotid arteries of male Sprague–Dawley rats weighing approximately 250 g. Total RNA were extracted from the arterial sections after 10 days. MicroRNA profile of the sample was compared with non-injured control.
2013-04-23 | E-GEOD-45433 | biostudies-arrayexpress
Project description:The proliferation and remodeling of vascular smooth muscle cells (VSMCs) is an important pathological event in atherosclerosis and restenosis. Here we report that microRNA-132 (miR-132) blocks vascular smooth muscle cells (VSMC) proliferation by inhibiting the expression of LRRFIP1 [leucine-rich repeat (in Flightless 1) interacting protein-1]. MicroRNA microarray revealed that miR-132 was upregulated in the rat carotid artery after catheter injury, which was further confirmed by quantitative real-time RT-PCR. Transfection of an miR-132 mimic significantly inhibited the proliferation of VSMCs, whereas transfection of an miR-132 antagomir increased it. Bioinformatics showed that LRRFIP1 is a target candidate of miR-132. miR-132 down-regulated luciferase activity driven by a vector containing the 3’-untranslated region of Lrrfip1 in a sequence-specific manner. LRRFIP1 induced VSMC proliferation. Immunohistochemical analysis revealed that Lrrfip1 was clearly expressed along with the basal laminar area of smooth muscle, and its expression pattern was disrupted 7 days after arterial injury LRRFIP1 mRNA was decreased 14 days after injury. Delivery of miR-132 to rat carotid artery attenuated neointimal proliferation in carotid artery injury models. Our results suggest that miR-132 is a novel regulator of VSMC proliferation that represses neointimal formation by inhibiting LRRFIP1 expression.
2013-04-23 | GSE45433 | GEO
Project description:To profile single-cell transcriptome and analyze the diversity of cell types present in human atherosclerotic tissue specimens (carotid artery, CAR), we carried out scRNA-seq from 10 different patients.
2023-11-08 | GSE247238 | GEO
Project description:Recently, we showed that disturbed flow caused by a partial ligation ofmouse carotid artery rapidly induces atherosclerosis. Analysis of mechanosenstive microRNA in the mouse carotid endothelium. In this study, we examined the microRNAs that respond differentially to blood flow pattern in the mouse carotid endothelium. We surgically induced disturbed blood flow in the left common carotid cartery (LCA) using partial carotid ligation surgery while the right carotid artery was left undisturbed. The hypothesis tested here is that turbulent or disturbed blood flow across the left carotid artery endothelium will affect endothelial genes and microRNAS. Identifying flow-sensitive microRNAs will provide important information about how endothelium responds to d-flow and regulates endothelial function and progression of atherosclerosis. Deter- mining the functional importance of these novel mechanosensitive microRNAS may provide important insights into understanding vascular biology and atherosclerosis. We used 6- to 8-week-old male C57Bl/6 mice (The Jackson Laboratory) according to the approved Institutional Animal Care and Use Committee protocol by Emory University. Mice were subjected to partial carotid ligation surgery under anesthesia. Briefly, 3 of 4 caudal branches of LCA (left external carotid, internal carotid, and occipital artery) were ligated with 6-0 silk suture, although the superior thyroid artery was left intact. Development of low and oscillatory blood flow in the Left Carotid Artery of each mouse was determined by ultrasound measurements.
2014-01-13 | E-GEOD-52243 | biostudies-arrayexpress
Project description:We profiled the single-cell transcriptome and analyzed the diversity of cell types present in human atherosclerotic tissue specimens (carotid artery, CAR). Therefore we carried out scRNA-seq from 7 different patients.
2025-11-04 | GSE294291 | GEO
Project description:Carotid artery stenosis (CAS) is a major cause of cardiovascular diseases, such as myocardial infarction and stroke. Mitochondrial dysfunction can trigger the onset of these conditions. CUB Domain Containing Protein 1 (CDCP1) is a transmembrane protein that has been demonstrated to contribute to various tumors and myocardial infarction; however, its role in carotid artery stenosis has not yet been reported. In this study, we investigated how CDCP1 affects cellular activity by regulating mitochondrial autophagy, and we propose that 8-isopentenylnaringenin (8-PN) may promote autophagy and alleviate carotid artery stenosis by reducing the expression of CDCP1. CDCP1 is upregulated in vascular smooth muscle cells within a carotid artery stenosis model, as demonstrated by studies conducted both in vivo and in vitro. Knocking down CDCP1 enhanced mitochondrial autophagy by upregulating ATG4A, leading to a reduction in reactive oxygen species (ROS) release and protection of cell viability. Moreover, both in vitro and in vivo experiments confirmed that 8-PN effectively decreases CDCP1 expression, activates cellular autophagy, and mitigates the progression of carotid artery stenosis. These findings highlight the importance ofCDCP1 in carotid artery stenosis and underscore the capability as a therapeutic option for this condition.
2025-12-30 | GSE285538 | GEO
Project description:This study was conducted in order to assess the effects of the compound Mycophenolate mofetil (MMF), an inhibitor of the enzyme inosine monophosphate dehydroxygenase (IMPDH) with a strong cytostatic effect on T-cells, on the phenotype of human carotid artery stenosis in humans in vivo. This was done at the transcriptome level by comparing the gene expression profiles of carotid endarterectomy samples from patients with carotid artery stenosis (>70% diameter stenosis on angiography) that were randomly assigned to treatment with MMF 1000 mg (N=9) or Placebo (N=11), respectively. MMF or placebo was given for at least 2 weeks prior to undergoing carotid endarterectomy (CEA).
2009-02-01 | GSE13922 | GEO
Project description:Carotid artery disease is frequent and can result in chronic modest hypoperfusion of the brain causing cognitive impairments even if classified asymptomatic without a transient ischemic attack or stroke. Paracrine Interleukin 6 (IL 6) improves functional outcome after stroke. However, in carotid artery disease it might have adverse long-term effects. With this exploratory study, we investigated the effect of paracrine IL 6 on cerebral remodeling in early stages after asymptomatic carotid artery occlusion. Therewith we aimed to distinguish IL 6 dependent targets with beneficial effects for long-term outcome from factors causing the detrimental long-term effects of IL 6. To mimic a human asymptomatic carotid artery disease, we used a mouse model of unilateral common carotid artery (CCA) occlusion. We developed a mouse model for inducible paracrine cerebral IL 6 expression (Cx30-Cre-ERT2;FLEX IL6) and induced IL 6 two days after CCA occlusion. We studied the effects of paracrine IL 6 after CCA occlusion on neuronal connectivity using diffusion tensor imaging and on local proteome regulations of the hypo-perfused striatum and contralateral motor cortex using mass spectrometry of laser capture micro-dissected tissues. Paracrine IL-6 induced cerebral remodeling leading to increased inter-hemispheric connectivity and changes in motor system connectivity. We identified changes in local protein abundance which might have adverse effects on functional outcome such as upregulation of Synuclein gamma (Sncg) or downregulation of Proline Dehydrogenase 1 (Prodh). However, we also identified changes in local protein abundance having potentially beneficial effects such as upregulation of Caprin1 or downregulation of GABA transporter 1 (Gat1).
2022-01-27 | PXD029737 | Pride